Patent landscape of nanotechnology - based nucleic acid delivery systems for breast cancer therapies.

ABSTRACT:

Background

Breast cancer is the most prevalent malignancy among women worldwide and remains a major public health concern. Conventional treatments are often limited by adverse effects and resistance. Nucleic acid-based gene therapies, supported by nanoparticle delivery systems, offer target and efficient therapeutic alternatives. The growing number of related patents about nanotechnology-based nucleic acid delivery systems for breast cancer treatment highlights the importance of understanding this landscape to advance research and innovation. Therefore, this study aimed to analyze the global patent landscape related to nanotechnology-based delivery systems for nucleic acid therapies in breast cancer, highlighting key technological platforms, emerging trends, and opportunities for r

SUBMITTER: Silva MJ 

PROVIDER: S-EPMC12847028 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature